Literature DB >> 26714647

Detection of bacteria in middle ear effusions based on the presence of allergy: does allergy augment bacterial infection in the middle ear?

Woo Jin Kim1, Byung-Guk Kim2, Ki-Hong Chang3, Jeong-Hoon Oh4,5.   

Abstract

BACKGROUND: Bacterial infection, Eustachian tube dysfunction, allergies, and immunologic factors are major causes of otitis media with effusion (OME). However, the exact pathogenesis of OME is still unclear. This study evaluated whether allergy influences bacterial growth in middle ear effusions. MATERIALS: Fifty-four samples were obtained from OME patients 3-10 years of age who underwent ventilation tube insertion and were divided into two groups based on the presence of allergy as determined using the multiple allergosorbent test (MAST). Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis bacterial DNA in the middle ear effusions was analyzed using polymerase chain reaction. Overall detection rates and those for each species were compared between the two groups.
RESULTS: Of the 54 middle ear effusion samples, 38 (70.4 %) contained bacterial DNA and 14 (36.8 %) of these contained DNA from multiple species. S. pneumoniae was detected in 27 samples (50 %), H. influenzae in 17 samples (31.4 %), and M. catarrhalis in 9 samples (16.6 %). There was no significant difference in the bacterial detection rates between the middle ear effusions of the MAST-positive and MAST-negative groups.
CONCLUSION: The rate of bacteria detection in middle ear effusions did not differ between allergic and non-allergic children.

Entities:  

Mesh:

Year:  2015        PMID: 26714647      PMCID: PMC4696230          DOI: 10.1186/s40463-015-0111-5

Source DB:  PubMed          Journal:  J Otolaryngol Head Neck Surg        ISSN: 1916-0208


Background

Otitis media with effusion (OME), fluid persisting in the middle ear cavity for more than 3 months, has been attributed to various causes [1]. Eustachian tube dysfunction is one of the most important factors in the development of this disease [2-4]. However, the exact pathogenic mechanism of OME is unclear. Eustachian tube dysfunction, including obstruction and abnormal patency, can be caused by extrinsic and intrinsic factors due to infection or allergy. The role of allergies in Eustachian tube dysfunction has been emphasized. The rate of Eustachian tube function tympanometry abnormalities in a group of allergic rhinitis patients was higher than in healthy subjects [5]. These functional abnormalities may also be related to impairment of the mucociliary activity that facilitates reflow and aspiration of bacteria from the Eustachian tube [6]. The response to combined nasal instillation of bacteria and allergen in sensitized mice was more persistent than the response to either alone [7, 8]. Therefore, we hypothesized that the local allergic response in the middle ear can augment bacterial infection, which may lead to OME. The rates of the overall detection of bacteria and detection of multiple bacteria in middle ear effusion using polymerase chain reaction in MAST-positive and -negative groups (MAST, multiple allergosorbent test) The most common organisms that cause OME are Streptococcus pneumoniae, Haemophilus influenza, and Moraxella catarrhalis [2, 6, 9, 10]. Although the presence of these bacteria DNA does not mean that bacterial infection is one of the main causes of OME, there is increasing interest in the role of bacterial infection and associated inflammation as a cause of OME. Since respiratory infections and host immunity may be important in the pathophysiology of OME in children with Eustachian tube dysfunction, the presence of bacteria in OME can be affected by the patient’s immune status. Therefore, this study evaluated the correlation between allergy and bacterial infection in the middle ear of OME patients. In this study, the presence of bacterial infection in middle ear effusion (MEE) of the children younger than 12 years old was estimated from the detection rates of the bacterial pathogens S. pneumoniae, H. influenzae, and M. catarrhalis using polymerase chain reaction (PCR) and conventional culture methods. Among them, the detection rates of bacteria in the MEEs of patients with allergy according to the results of the multiple allergosorbent test (MAST) were compared with the rates in patients who did not have allergy.

Methods

This study was approved by the institutional review board and the parents provided informed consent before participation. The enrolled subjects consisted of 34 consecutive pediatric patients (19 boys, 15 girls) under 12 years old, who admitted our clinic for the insertion of ventilating tube due to OME persisting for more than 3 months. The subjects were divided into two groups according to the presence of allergy. To determine the presence of allergy, blood samples were collected before the insertion of ventilating tube for the Korean panel of the multiple allergosorbent test chemiluminescent assay (MAST-CLA) (MAST Immunosystems, Mountain View, CA, USA). This assay consists of 35 different specific IgE antibodies with associated allergens from food, mold, pollen, and inhalant allergens that are most frequently positive in Koreans. The MAST-CLA was performed according to the' manufacturer's instructions. The amount of the produced chemiluminescence, which is proportional to the amount of allergen-specific IgE in the test serum, was measured in a densitometer; the results were interpreted as classes 0, 0/1, 1, 2, 3, or 4 based on the amount of light emitted, with classes 2 to 4 considered positive results. At the time of tube placement surgery, the external auditory canal was irrigated with 70 % alcohol and then the middle ear fluid was collected using a suction collector (Storz®, Germany). The collected fluid was stored immediately at −70 °C for subsequent analysis. The genomic DNA was extracted by mixing 50 μL of the stored middle ear effusion with 900 μL of cell lysis solution, followed by a 10 min centrifugation at 15,000 rpm at room temperature. DNA was extracted using PCR premix (Bioneer®, Daejeon, South Korea). For PCR, P6 protein was used as a primer for Haemophilus influenzae, PBP 2B for Streptococcus pneumoniae, and the M46 clone for Moraxella catarrhalis. Thirty-five cycles of 95 °C, 55 °C, and 70 °C were performed using a DNA thermal cycler. To detect the amplified product, DNA was electrophoresed for 30 min in 2 % agarose gels. Specimens with consistent PCR results were used as positive controls and distilled water as a negative control. The overall detection rate and that for each bacterial species was compared between the MAST-positive and -negative groups using the chi-square test.

Results

Fifty-four ears of 34 children from 3–10 years old were enrolled in this study. Of the 54 ears, 15 were positive as determined by MAST, while the remaining 39 were negative. The mean ages of the children in the MAST-positive and -negative groups were 3.73 ± 2.25 years and 3.23 ± 0.93 years, respectively. The rate of bacteria detection using conventional culture methods was only 9.0 % (5/54) and the species cultured were S. pneumoniae, S. epidermidis, S. capitis, and α-hemolytic Streptococcus. The overall detection rate of bacterial DNA using PCR was 70.4 % (38 of 54 ears) (Table 1). In 14 of 38 ears (36.8 %), two or more bacterial species were detected in the same effusion sample. The overall detection rate of the bacteria did not differ significantly (p > 0.05) between the MAST-positive and -negative groups, nor did the detection rates of each bacterial species (Fig. 1). There was no significant difference in the detection rate of multiple bacteria between the two groups (Fig.1).
Table 1

The detection rates of major pathogenic bacteria in middle ear effusions using PCR in MAST-positive and -negative groups

Bacterial speciesNo (%) of PCR-positive specimens in the MAST-positive groupNo (%) of PCR-positive specimens in the MAST-negative group
S. pneumoniae 6 (40.0 %)21 (53.9 %)
H. influenzae 7 (46.7 %)10 (25.6 %)
M. catarrhalis 3 (20.0 %)6 (15.4 %)

PCR polymerase chain reaction; MAST multiple allergosorbent test

Fig. 1

The rates of the overall detection of bacteria and detection of multiple bacteria in middle ear effusion using polymerase chain reaction in MAST-positive and -negative groups (MAST, multiple allergosorbent test)

The detection rates of major pathogenic bacteria in middle ear effusions using PCR in MAST-positive and -negative groups PCR polymerase chain reaction; MAST multiple allergosorbent test

Discussion

This study demonstrates that the children with evidence of allergy were equally likely as children without evidence of allergy to demonstrate evidence of bacterial infection in PCR tested MEE specimens. Although this study did not demonstrate a positive relationship between allergy and the bacterial infection in the pathogenesis of OME. However, numerous studies have indicated that allergic subjects are more susceptible to OME than non-allergic controls. The combination of allergic and bacterial stimulation can augment the development of OME. Labadie et al. showed that lipopolysaccharide (LPS)-induced OME, in which LPS simulated bacterial exposure, was more prominent in allergic rats [11]. Ebmeyer et al. found that the reaction to combined bacteria and allergen in sensitized mice was more persistent than the response to either alone and a reaction was absent in mast cell-deficient mice [12]. However, the exact mechanism of the relationship between the presence of bacteria in middle ear effusion and systemic immunity is still not clear. Theoretically, nasal obstruction due to an allergy can lead to an increase in negative pressure in the nasopharynx, resulting secondarily in decreased Eustachian tube patency, and disturbance of its ciliary epithelial function with subsequent increase in the negative pressure in the middle ear cavity. Several theories have been proposed to explain the Eustachian tube dysfunction caused by allergic inflammation, including retrograde spread of edema, poor mucociliary function, and venous engorgement and hypersecretion of mucus [3]. It has been suggested that the development of OME is the result of improperly functioning barriers (mucociliary system, immune system, and Eustachian tube) conferring resistance to bacteria [13]. The pathogenesis of OME is related primarily to Eustachian tube dysfunction, including obstruction, abnormal patency, and non-optimally functioning ciliated epithelium [3, 14]. These conditions can facilitate the aspiration of nasopharyngeal secretions containing pathogenic bacteria into the middle ear cavity, leading to the development of OME. The high prevalence of this condition in children reflects immaturity of function of both the immune system and the Eustachian tubes. The Eustachian tube of the infants has a smaller caliber and shorter length and joins the nasopharynx at a more acute angle in relation to the adults. All of these features predispose to dysfunction of the Eustachian tube and therefore increased risk of infection [15]. The negative finding of our study indicates that the anatomical immaturity of the Eustachian tube in children may plays a major role in the development of OME due to the bacterial infection rather than allergy. Chronic OME due to Eustachian tube dysfunction caused by allergy tends to occur much more frequently in adults than in children [3]. The analysis of differences of the detection rates among various age groups was not performed in this study. It would be helpful to distinguish the different pathogenesis of OME between children and adults. There are several large literature reviews of the relationship of allergy to OME. Doyle concluded that allergy has been “reasonably well demonstrated” as a risk factor for otitis media.” [16]; Tewfik and Mazer determined that Th2 mediated allergic inflammation was found in MEE in patients with OME [17]. In a prospective, cohort study of patients cared for in a private community practice, all 89 OME patients proved to be atopic and specific allergy immunotherapy resolved 85 % of OME [18]. Although, these results support the hypothesis that OME is an immune mediated allergic disease, evidence for direct causal relationship between OME and allergy have been lacking. Recent study showed that the prevalence of allergic rhinitis was not different in 6- to 7-year-old children with OME and the reference group, suggesting a limited effect of allergy in the pathogenesis of OME in this age group [19]. Another study reported that no difference in Eustachian tube function was found in either the allergic rhinitis or control groups, which was interpreted as showing allergic rhinitis has little direct effect on Eustachian tube function [20]. One of the main reasons for the conflicting results regarding the relationship of allergy and OME in the literatures may due to non-controlled study designs, including diagnostic criteria for allergy and differing populations [21]. The reported incidence of allergic rhinitis in OME ranges from 14 % to as high as 89 % [17, 22]. For the diagnosis of allergy and determination of allergens, many procedures can be used: skin tests, provocation tests, the radio-allergosorbent test (RAST), and MAST-CLA. In this study, the presence of allergy was defined using the MAST-CLA system, which is used to detect allergen-specific IgE antibodies using enzyme-linked anti-human IgE and a chemiluminescent assay, as reported previously [23]. This test avoids the use of radioactive reagents used in other in vitro tests and it permits the simultaneous quantitative measurement of specific IgE directed against 35 different allergens [24]. MAST-CLA sensitivity, specificity, and precision equal those of RAST and skin prick tests [25]. However, the MAST-CLA frequently shows concurrent positive results for multiple allergens in a single panel test; hence the clinicians can be confused as to whether the results should be interpreted as multiple allergens, cross-reactivity, or false positives. In this study, we used MAST-CLA results for detecting allergen-specific IgE antibodies, not for the determination of the specific allergens. Therefore, the definition of allergy in our study population was likely reliable. The criteria for the presence of allergy and the allergens affecting nasal allergy should be studied further, because current diagnostic tests provide evidence only of an increased amount of specific IgE antibody in the skin or blood serum, which cannot be related directly to nasal mucosa and Eustachian tube. Another possible explanation for the negative correlation between the presence of allergy and OME is whether the middle ear mucosa is the target organ of the allergic inflammation. As mentioned above, the suggested mechanism of allergic involvement in OME is Eustachian dysfunction. However, not all allergic patients develop OME nor do all OME patients have allergies. Yeo et al. evaluated the relationship of serum and effusion fluid immunoglobulin concentrations, with the presence of bacteria in effusion fluid determined by culture and PCR, and found no correlation between the immunoglobulin concentration in middle ear effusion and the presence of bacteria in the effusion, while the serum immunoglobulin concentration was significantly related to the presence of effusion bacteria [26]. They suggested that the higher serum antibody concentration in bacteria-positive OME patients was due to a systemic immune reaction caused by inflammation in response to a local infection in the middle ear cavity. The relationship between systemic immune reaction and local infection in middle ear effusion should be evaluated in further studies. Bacteria detection rates of up to 94.5 % have been reported in middle ear effusions using PCR; we observed a 70.4 % overall detection rate. The detection of bacterial DNA by PCR does not imply the existence of metabolically active bacteria, since PCR assays rely on the detection of genetic material regardless of the viability of the organism. The discrepancy between the low detection rate of the bacteria using conventional culture and the high detection rate using PCR can be explained by the use of antibiotics before myringotomy and the insertion of ventilating tubes, the involvement of biofilms in the progression of infection, and intracellular infection persistence of bacteria in the middle ear mucosa [10, 27, 28].

Conclusion

Bacteria were found in more than 70 % of the middle ear effusions, with more than one third showing multiple bacteria. The bacteria detection rates did not differ between allergic and non-allergic children.
  28 in total

Review 1.  Should we screen every child with otitis media with effusion for allergic rhinitis?

Authors:  S Miceli Sopo; G Zorzi; M Calvani
Journal:  Arch Dis Child       Date:  2004-03       Impact factor: 3.791

Review 2.  Is otitis media with effusion a biofilm infection?

Authors:  N Fergie; R Bayston; J P Pearson; J P Birchall
Journal:  Clin Otolaryngol Allied Sci       Date:  2004-02

3.  Bacteriological and PCR analysis of clinical material aspirated from otitis media with effusions.

Authors:  U Gok; Y Bulut; E Keles; S Yalcin; M Z Doymaz
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2001-07-30       Impact factor: 1.675

Review 4.  Allergic rhinitis augments the response to a bacterial sinus infection in mice: A review of an animal model.

Authors:  Robert Naclerio; Christopher Blair; Xiaohong Yu; Yu-Sung Won; Usama Gabr; Fuad M Baroody
Journal:  Am J Rhinol       Date:  2006 Sep-Oct

5.  Allergy increases susceptibility to otitis media with effusion in a rat model. Second place--Resident Clinical Science Award 1998.

Authors:  R F Labadie; B S Jewett; C F Hart; J Prazma; H C Pillsbury
Journal:  Otolaryngol Head Neck Surg       Date:  1999-12       Impact factor: 3.497

6.  Allergic inflammation enhances bacterial sinusitis in mice.

Authors:  C Blair; M Nelson; K Thompson; S Boonlayangoor; L Haney; U Gabr; F M Baroody; R M Naclerio
Journal:  J Allergy Clin Immunol       Date:  2001-09       Impact factor: 10.793

Review 7.  The link between allergic rhinitis and otitis media.

Authors:  William J Doyle
Journal:  Curr Opin Allergy Clin Immunol       Date:  2002-02

8.  Evaluation of allergen-specific IgE antibodies by MAST for the diagnosis of nasal allergy.

Authors:  S Ogino; K Bessho; T Harada; M Irifune; T Matsunaga
Journal:  Rhinology       Date:  1993-03       Impact factor: 3.681

Review 9.  Otitis media with effusion: disease or defense? A review of the literature.

Authors:  J A de Ru; J J Grote
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2004-03       Impact factor: 1.675

10.  Detection rates of bacteria in chronic otitis media with effusion in children.

Authors:  Chul-Won Park; Jang-Hee Han; Jin-Hyeok Jeong; Seok-Hyun Cho; Mi-Jung Kang; Kyung Tae; Seung-Hwan Lee
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

View more
  5 in total

1.  Therapeutic efficacy of azithromycin and acetylcysteine in chronic otitis media with effusion.

Authors:  Irena Babić; Tomislav Baudoin; Robert Trotić; Vladimir Bedeković
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-21       Impact factor: 2.503

Review 2.  What Role Does Allergy Play in Chronic Ear Disease and Laryngitis?

Authors:  Michael P Platt; Christopher D Brook; Jacob Kuperstock; John H Krouse
Journal:  Curr Allergy Asthma Rep       Date:  2016-10       Impact factor: 4.806

Review 3.  Interaction Between Allergy and Middle Ear Infection.

Authors:  Jeong-Hoon Oh; Woo Jin Kim
Journal:  Curr Allergy Asthma Rep       Date:  2016-09       Impact factor: 4.806

4.  Erratum to: Detection of bacteria in middle ear effusions based on the presence of allergy: does allergy augment bacterial infection in the middle ear?

Authors:  Woo Jin Kim; Byung-Guk Kim; Ki-Hong Chang; Jeong-Hoon Oh
Journal:  J Otolaryngol Head Neck Surg       Date:  2016-02-19

5.  Evaluation of antibiotic susceptibility patterns of pathogens isolated from routine laboratory specimens at Ndola Teaching Hospital: A retrospective study.

Authors:  Warren Chanda; Mespa Manyepa; Ephraim Chikwanda; Victor Daka; Justin Chileshe; Mathias Tembo; Joseph Kasongo; Allen Chipipa; Ray Handema; John A Mulemena
Journal:  PLoS One       Date:  2019-12-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.